Gao-feng Zha

205 Luoshi Road
Wuhan, 430070, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

CD73-LNPs promote antitumor T-cell immunity via amplifying TLR3-mediated immunostimulatory dendritic cell activation.

CD73-LNPs promote antitumor T-cell immunity via amplifying TLR3-mediated immunostimulatory dendritic cell activation.

Journal: Journal of translational medicine
Published: April 04, 2026

Fluorinated lipid nanoparticles enable in vivo CAR-macrophage therapy in solid tumor and enhance anti PD-L1 immunotherapy.

Fluorinated lipid nanoparticles enable in vivo CAR-macrophage therapy in solid tumor and enhance anti PD-L1 immunotherapy.

Journal: Biomaterials
Published: December 08, 2025

In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus.

In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus.

Journal: The New England journal of medicine
Published: September 17, 2025

α-GalCer-LNP ehanced mRNA delivery and activates natural killer T cells for superior tumor immunotherapy.

α-GalCer-LNP ehanced mRNA delivery and activates natural killer T cells for superior tumor immunotherapy.

Journal: Materials today. Bio
Published: March 10, 2025

Enhancing the potency of 5T4 mRNA vaccine by CD70 mRNA-LNPs through ADCC and T cell boosting in prostate cancer therapy.

Enhancing the potency of 5T4 mRNA vaccine by CD70 mRNA-LNPs through ADCC and T cell boosting in prostate cancer therapy.

Journal: Journal of nanobiotechnology
Published: February 28, 2025

Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity.

Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity.

Journal: Oncoimmunology
Published: July 01, 2024

Personalized membrane protein vaccine based on a lipid nanoparticle delivery system prevents postoperative recurrence in colorectal cancer models.

Personalized membrane protein vaccine based on a lipid nanoparticle delivery system prevents postoperative recurrence in colorectal cancer models.

Journal: Acta biomaterialia
Published: June 27, 2024

α-Lactalbumin mRNA-LNP Evokes an Anti-Tumor Effect Combined with Surgery in Triple-Negative Breast Cancer.

α-Lactalbumin mRNA-LNP Evokes an Anti-Tumor Effect Combined with Surgery in Triple-Negative Breast Cancer.

Journal: Pharmaceutics
Published: June 04, 2024

Delivery of mRNA Vaccine with 1, 2-Diesters-Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy.

Delivery of mRNA Vaccine with 1, 2-Diesters-Derived Lipids Elicits Fast Liver Clearance for Safe and Effective Cancer Immunotherapy.

Journal: Advanced healthcare materials
Published: August 16, 2023

Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice.

Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice.

Journal: Antiviral research
Published: April 22, 2023

Evolutionary dissection of monkeypox virus: Positive Darwinian selection drives the adaptation of virus-host interaction proteins.

Evolutionary dissection of monkeypox virus: Positive Darwinian selection drives the adaptation of virus-host interaction proteins.

Journal: Frontiers in cellular and infection microbiology
Published: October 28, 2022

Benzimidazole analogues as efficient arsenals in war against methicillin-resistance staphylococcus aureus (MRSA) and its SAR studies.

Benzimidazole analogues as efficient arsenals in war against methicillin-resistance staphylococcus aureus (MRSA) and its SAR studies.

Journal: Bioorganic chemistry
Published: July 01, 2021
Showing 1-12 of 28

Last Updated: 09/26/2026